Klaus Dinkel

Dortmund, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

An Imidazo[2,1-b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α-Hemolysin by Blocking the Pullout of Its Stem Domain.

An Imidazo[2,1-b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α-Hemolysin by Blocking the Pullout of Its Stem Domain.

Journal: ChemMedChem
Published: December 08, 2025

Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm.

Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm.

Journal: Frontiers in immunology
Published: June 23, 2025

The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm.

The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm.

Journal: Frontiers in immunology
Published: January 03, 2025

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Journal: Cell host & microbe
Published: August 23, 2024

P2X7 receptor antagonism suppresses epileptiform-like activity in an inflammation-primed human iPSC-derived neuron model of drug-resistant epilepsy.

P2X7 receptor antagonism suppresses epileptiform-like activity in an inflammation-primed human iPSC-derived neuron model of drug-resistant epilepsy.

Journal: British journal of pharmacology
Published: August 21, 2024

TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia.

TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia.

Journal: The EMBO journal
Published: June 14, 2024

P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.

P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.

Journal: Theranostics
Published: April 12, 2024

Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes.

Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes.

Journal: Purinergic signalling
Published: March 25, 2023

Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice.

Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice.

Journal: British journal of pharmacology
Published: August 28, 2021

Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain.

Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain.

Journal: European journal of pharmacology
Published: July 03, 2018

TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.

TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.

Journal: Oncotarget
Published: September 29, 2017

Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.

Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.

Journal: British journal of pharmacology
Published: June 12, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026